Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1998-06-25
1999-11-30
Huang, Evelyn Mei
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514267, 544252, 546 84, 546 81, A61K 3147, A61K 31505, C07D47104
Patent
active
059943661
ABSTRACT:
The present invention relates to certain tetrahydroimidazo[2,1-a]isoquinoline derivatives according to formula I wherein X is a group (A) or (B) ##STR1## R.sup.1, R.sup.2 and R.sup.3, which may be the same or different, each represent one or more substituents selected from hydrogen, C.sub.1-6 alkyl, C.sub.3-6 cycloalkyl, C.sub.1-6 alkoxy, C.sub.1-6 alkylthio, C.sub.4-6 cycloalkenyl, C.sub.2-6 alkenyl, C.sub.2-6 alkynyl and halogen;
REFERENCES:
patent: 3624093 (1971-11-01), Sulkowski
patent: 4100165 (1978-07-01), Houlihan
Matechka D et al. J. Med. Chem. 39, 4704-4716, Nov. 1996.
M. Chaykovskyet et al., Journal of Organic Chemistry, 35:4:1178-1180, 1970.
Leysen Dirk
Ruigt Gerardus Stephanus Franciscus
Akzo Nobel nv
Blackstone William M.
Huang Evelyn Mei
Sullivan Michael G.
LandOfFree
Tetrahydroimidazo[2,1-A]isoquinoline derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Tetrahydroimidazo[2,1-A]isoquinoline derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tetrahydroimidazo[2,1-A]isoquinoline derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1672988